Abstract
In cancer research, animal models constitute an essential aspect of preclinical investigations. In various human malignancies, such as ovarian, breast, colon, liver cancers, and tumors in the eye, nonhuman tumor models have aided in determining the path of carcinogenesis and estimating diagnostic and treatments. In vitro investigations have limitations since they are done outside of the human body’s complicated milieu. The complete scope of pathophysiological alterations that occur in neoplasms can be revealed by probing the cellular processes of tumor growth within the complexity of an organism. This chapter intends to construct prototypes that parodist all aspects of retinoblastoma, including its genesis, development, and metastasis, using molecular and imaging technology breakthroughs. In retinoblastoma research, combining xenograft and genetic models has and will support the way for a deeper understanding of retinoblastoma tumor biology and devising and testing viable diagnostic and therapy methods.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
American Society of Clinical Oncology, June 03–07, 2011, Chicago, Illinois.
Ancona L, Dalvin D, Lauren A, Shields CL (2020) Modern treatment of retinoblastoma a review. Indian J Ophthalmol 68(11):2356–2365
Brigitte L Thériault, Helen Dimaras, Brenda L Gallie, Timothy W Corson (2015). The genomic landscape of retinoblastoma:a review. Clinical & experimental ophthalmology. 42(1):33–52
Burke JR, Hura GL, Rubin SM (2012) Structures of inactive retinoblastoma protein reveal multiple mechanisms for cell cycle control. Genes Dev 26:1156–1166
Chang L, Ying-** D (2013) Retinoblastoma: concerning its initiation and treatment. Int J Ophthalmol 6(3):397–401
Diana P, Marcela F, Leonela L, Florencia G, Irene S, Klaus B (2017) RB1 gene mutations in argentine retinoblastoma patients. Implications for genetic counseling. PLoS One 12(12):e0189736. https://doi.org/10.1371/journal.pone.0189736
Eleanor M, Pritchard Michael A, Dyer KGR (2016) Progress in small molecule therapeutics for the treatment of retinoblastoma. Mini Rev Med Chem 16(6):430–454
Golabchi K, Rahim SJ, Nazila A, Fatemeh M, Abdullah M, Sadri NJ, Aria M, Hasan R, Hamed M (2017) MicroRNAs in retinoblastoma potential diagnostic and therapeutic biomarkers. J Cell Physiol 233(4):3016–3023. https://doi.org/10.1002/jcp.26070
Guzman F, Fazeli Y, Khuu M, Salcido K, Singh S, Benavente CA (2020) Retinoblastoma tumor suppressor protein roles in epigenetic regulation. Cancers 12(10):2807. https://doi.org/10.3390/cancers12102807
Ifat SZ, Ettel G, Yoreh B, Barak YR (2021) Suprachoroidal delivery of bevacizumab in rabbit in vivo eyes: rapid distribution throughout the posterior segment. Eur J Pharm Biopharm 169:200–210
Kaneko A, Suzuki S (2003) Eye-preservation treatment of retinoblastoma with vitreous seeding. Jpn J Clin Oncol 33:601–607
Knudson AG (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci 68(4):820–823. https://doi.org/10.1073/pnas.68.4.820
McFall RC, Sery TW, Makadon M (1977) Characterization of a new continuous cell line derived from a human retinoblastoma. Cancer Res 37:1003–1010
Mendelsohn ME, Abramson DH, Madden T, Tong W, Tran HT, Dunkel IJ (1998) Intraocular concentrations of chemotherapeutic agents after systemic or local administration. Arch Ophthalmol 16(9):1209–1212
Mirzaei H, Sharareh G, Soodabeh S, Amirhossein S, Reza JM, Reza MH, Mahdi HS, Amir A (2016) MicroRNAs as potential diagnostic and prognostic biomarkers in melanoma. Eur J Cancer 53:25–32. https://doi.org/10.1016/j.ejca.2015.10.009
Patra JK, Gitishree D, Fernandes FL, Ramos CEV, del Pilar R-TM, Susana A-TL, Armando D-TL, Renato G, Kumara SM, Shivesh S, Solomon H, Shin H-S (2018) Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnol 16(1):71. https://doi.org/10.1186/s12951-018-0392-8
Robanus-Maandag E, Dekker M, Van der Valk M, Carrozza ML, Jeanny JC, Dannenberg JH, Berns A, Te Riele H (1998) p107 is a suppressor of retinoblastoma development in pRb-deficient mice. Genes Dev 12(11):1599–1609. https://doi.org/10.1101/gad.12.11.1599
Shin Jeong Kang and Hans E. Grossniklaus (2010). Rabbit model of retinoblastoma. Journal of Biomedicine and Biotechnology 2011.
Tomar S, Sethi R, Sundar G, Quah TC, Quah BL, Lai PS (2017) Mutation spectrum of RB1 mutations in retinoblastoma cases from Singapore with implications for genetic management and counselling. PLoS One 12(6):e0178776. https://doi.org/10.1371/journal.pone.0178776
Windle JJ, Albert DM, O’Brien JM, Marcus DM, Disteche CM, Bernards R, Mellon PL (1990) Retinoblastoma in transgenic mice. Nature 343:665–669
Xu K, Rosenwaks Z, Beaverson K, Cholst I, Veeck L, David Abramson H (2004) Preimplantation genetic diagnosis for retinoblastoma: the first reported liveborn. Am J Ophthalmol 137(1):18–23. https://doi.org/10.1016/s0002-9394(03)00872-9
Yamane T, Kaneko A, Mohri M (2004) The technique of ophthalmic arterial infusion therapy for patients with intraocular retinoblastoma. Int J Clin Onco 9(2):69–73. https://doi.org/10.1007/s10147-004-0392-6
Zhang F, Tagen M, Throm S, Mallari J, Miller L, Guy RK, Dyer MA, Williams RT, Roussel MF, Nemeth K, Zhu F, Zhang J, Lu M, Panetta JC, Boulos N, Stewart CF (2011) Whole-body physiologically based pharmacokinetic model for Nutlin-3a in mice after intravenous and oral administration. Drug Metab Dispos 39:15–21
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 Springer Nature Singapore Pte Ltd.
About this entry
Cite this entry
Subbaraj, G.K. et al. (2023). Therapeutic Approaches and Models in Retinoblastoma. In: Pathak, S., Banerjee, A., Bisgin, A. (eds) Handbook of Animal Models and its Uses in Cancer Research. Springer, Singapore. https://doi.org/10.1007/978-981-19-3824-5_58
Download citation
DOI: https://doi.org/10.1007/978-981-19-3824-5_58
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-19-3823-8
Online ISBN: 978-981-19-3824-5
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences